Immuron Limited (IMRN)
IMRN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-06-30, https://www.sec.gov/Archives/edgar/data/1660046/000121390025091414/0001213900-25-091414-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-06-30. Converted from AUD at 1.4266 per USD (ECB reference rate).
Profile
| Field | Value |
|---|---|
| Ticker | IMRN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Australia |
| IPO year | 2017 |
| SEC CIK | 0001660046 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | C3 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $5.1M |
| Net income | -$3.7M |
| Operating income | Not in SEC XBRL data |
| Net margin | -71.6% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.6× |
Reported in AUD; shown in US dollars.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2025-10-03 |
| Latest annual report ANNUAL REPORT | 20-F | 2026-09-24 |
| Latest quarterly / interim REPORT OF FOREIGN PRIVATE ISSUER | 6-K | 2026-10-13 |
Source: SEC EDGAR submissions feed, 421 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BOLT | Bolt Biotherapeutics Inc. | $4.29 | +1.06% | $8.3M |
| ADIL | Adial Pharmaceuticals Inc | $3.29 | -6.00% | $8.6M |
| MBRX | Moleculin Biotech Inc. | $0.4352 | +5.15% | $8.9M |
| CMMB | Chemomab Therapeutics Ltd. American Depositary Share | $1.24 | -10.79% | $9.0M |
| CNSP | CNS Pharmaceuticals Inc. | $5.35 | +3.08% | $7.8M |
| TCRT | Alaunos Therapeutics Inc. | $3.03 | +188.57% | $7.7M |
| CURX | Curanex Pharmaceuticals Inc | $4.88 | 0.00% | $7.7M |
| CALC | CalciMedica Inc. | $1.12 | -7.05% | $7.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier